DNP (DNP Selectome Fund) Research & Development: $0.0 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DNP DNP Select Income Fund Inc DNP
33 GF Score
Price $10.89
! 7 Warning Signs
View Full Analysis

What is DNP Selectome Fund Research & Development?

DNP Selectome Fund DNP -0.23% 33 Research & Development is $0.0 Mil as of Apr. 2026. GuruFocus rates DNP with a GF Score™ of 33/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. DNP Selectome Fund's Research & Development for the six months ended in Apr. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was $0.0 Mil.

DNP Selectome Fund  (NYSE:DNP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DNP Selectome Fund Research & Development Related Terms

DNP Selectome Fund Research & Development Historical Data

* Premium members only.

The historical data trend for DNP Selectome Fund's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DNP Selectome Fund Research & Development Chart

DNP Selectome Fund Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

DNP Selectome Fund Semi-Annual Data
Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DNP
33GF Score
DNP Select Income Fund Inc DNP
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DNP Selectome Fund Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
DNP Selectome Fund (DNP) has a Research & Development of $0.0 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on DNP Selectome Fund and its competitors.
Is DNP Selectome Fund's Research & Development too high?
DNP Selectome Fund's current Research & Development is $0.0 Mil. Overall, DNP Selectome Fund has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does DNP Selectome Fund's Research & Development compare to CNS and FHI?
DNP Selectome Fund's Research & Development of $0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on DNP Selectome Fund and its competitors. DNP Selectome Fund's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DNP Selectome Fund stock overvalued right now?
DNP Selectome Fund (DNP) has a current Research & Development of $0.0 Mil. The current Research & Development is $0.0 Mil. DNP Selectome Fund's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For DNP Selectome Fund (DNP), the current Research & Development is $0.0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DNP Selectome Fund Business Description

Address 10 South Wacker Drive, Suite 1900, 19th Floor, Chicago, IL, USA, 60606
DNP Select Income Fund Inc is a closed-ended investment management fund. Its investment objectives are current income and long-term growth of income, with capital appreciation as a secondary objective. The Fund seeks to achieve its investment objectives by investing mainly in a diversified portfolio of equity and fixed-income securities of companies in the public utilities industry. Under normal market conditions, more than 65% of the Fund's total assets are invested in securities of public utility companies engaged in the production, transmission, or distribution of electric energy, gas, or telephone services.
33GF Score

Get the complete analysis for DNP

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.89
Price